Cancer in pathologically confirmed multiple system atrophy

ConclusionThe evidence from this retrospective cohort found no significant clinical association of MSA with breast cancer or other cancers. These results do not exclude the possibility that knowledge about synuclein pathology at the molecular level in cancer may lead to future discoveries and potential therapeutic targets for MSA.
Source: Clinical Autonomic Research - Category: Research Source Type: research